- Home
- SQNS vs TLSA Comparison
SQNS vs TLSA Comparison
Compare SQNS & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SQNS
- TLSA
- Stock Information
- Founded
- SQNS 2003
- TLSA 2013
- Country
- SQNS France
- TLSA United Kingdom
- Employees
- SQNS N/A
- TLSA N/A
- Industry
- SQNS Semiconductors
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- SQNS Technology
- TLSA Health Care
- Exchange
- SQNS Nasdaq
- TLSA Nasdaq
- Market Cap
- SQNS 46.5M
- TLSA 187.0M
- IPO Year
- SQNS 2011
- TLSA 2000
- Fundamental
- Price
- SQNS $4.52
- TLSA $1.45
- Analyst Decision
- SQNS Strong Buy
- TLSA
- Analyst Count
- SQNS 1
- TLSA 0
- Target Price
- SQNS $7.50
- TLSA N/A
- AVG Volume (30 Days)
- SQNS 9.6M
- TLSA 246.7K
- Earning Date
- SQNS 08-22-2025
- TLSA 07-22-2025
- Dividend Yield
- SQNS N/A
- TLSA N/A
- EPS Growth
- SQNS N/A
- TLSA N/A
- EPS
- SQNS 2.16
- TLSA N/A
- Revenue
- SQNS $38,858,000.00
- TLSA N/A
- Revenue This Year
- SQNS N/A
- TLSA N/A
- Revenue Next Year
- SQNS $93.87
- TLSA N/A
- P/E Ratio
- SQNS $1.81
- TLSA N/A
- Revenue Growth
- SQNS 40.06
- TLSA N/A
- 52 Week Low
- SQNS $0.95
- TLSA $0.63
- 52 Week High
- SQNS $5.50
- TLSA $1.91
- Technical
- Relative Strength Index (RSI)
- SQNS 87.95
- TLSA 48.43
- Support Level
- SQNS $1.34
- TLSA $1.43
- Resistance Level
- SQNS $2.68
- TLSA $1.81
- Average True Range (ATR)
- SQNS 0.52
- TLSA 0.09
- MACD
- SQNS 0.29
- TLSA -0.02
- Stochastic Oscillator
- SQNS 76.77
- TLSA 18.53
About SQNS Sequans Communications S.A.
Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its offer 5G/4G chips and modules fully optimized for non-smartphone devices. The company covers applications such as smart mobility and logistics, smart utility meters, smart cities, smart industries, e-health and wellness, and smart homes to name few. The Company has one operating segment, which is the design and marketing of semiconductor components for cellular wireless systems. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.